FDA (Drugs) recall action 65690
The FDA (Drugs) publishes a recall like this one as 265 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 265 pages.
Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 112 mcg may have potentially been mislabeled as the following drug: RALTEGRAVIR, Tablet, 400 mg, NDC 00006022761, Pedigree: AD60272_19, EXP: 5/22/2014.
Labeling: Label Mixup: DOCUSATE SODIUM, Capsule, 250 mg may have potentially been mislabeled as one of the following drugs: PIOGLITAZONE, Tablet, 15 mg, NDC 00591320530, Pedigree: AD25452_10, EXP: 4/30/2014; PHOSPHORUS, Tablet, 250 mg, NDC 64980010401, Pedigree: AD54498_1, EXP: 5/20/2014; LACTOBACILLUS GG, Capsule, 0, NDC 49100036374, Pedigree: AD65457_16, EXP: 5/24/2014; guaiFENesin ER, Table
Labeling: Label Mixup: tiZANidine HCl, Tablet, 2 mg may have potentially been mislabeled as the following drug: NIACIN TR, Tablet, 500 mg, NDC 00904434260, Pedigree: W002969, EXP: 6/11/2014.
The agency’s own wording, quoted from the enforcement report.
The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.
Aidapak Services is recalling Levothyroxine Sodium 112 mcg tablets because they may have been mislabeled as Raltegravir 400 mg.
Aidapak Services, LLC is recalling Docusate Sodium capsules because they may have been mislabeled as other medications. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling Tizanidine HCl 2 mg tablets that may have been mislabeled as Niacin TR 500 mg.
Aidapak Services, LLC is recalling Pyridoxine HCL 25 mg tablets because they may have been mislabeled as Torsemide 10 mg.
Aidapak Services is recalling Valsartan 40 mg tablets because they may have been mislabeled as Valsartan 80 mg or Zinc Sulfate 50 mg.
Aidapak Services is recalling Mycophenolic Acid tablets that may be mislabeled as Methazolamide. The error could lead to patients taking the wrong medication.
Aidapak Services, LLC is recalling Modafinil 200 mg tablets because they may have been mislabeled as Omega-3-Acid Ethyl Esters capsules.
Aidapak Services is recalling Efavirenz 600 mg tablets because they may have been mislabeled as Niacin ER 500 mg.
Aidapak Services is recalling Famciclovir 500 mg tablets because they may have been mislabeled as Tolterodine or Thiamine.
Aidapak Services, LLC is recalling prednisone 20 mg tablets that may have been mislabeled as methylprednisolone 4 mg.
Aidapak Services, LLC is recalling glyBURIDE tablets because they may have been mislabeled as CYPROHEPTADINE HCL or AMANTADINE HCL.
Aidapak Services is recalling 811 tablets of 20 mg Atorvastatin Calcium because they may be mislabeled as other drugs.
Aidapak Services, LLC is recalling Mesalamine DR capsules that may have been mislabeled as Chlorophyllin Copper Complex tablets.
Aidapak Services is recalling Oxybutynin Chloride tablets that may be mislabeled as Pimozide. The error could lead to patients receiving the wrong medication.
Aidapak Services, LLC is recalling Pyridoxine HCL 100 mg tablets because they may have been mislabeled as other drugs. The repacked drugs were distributed in four western states.
Aidapak Services is recalling 1,101 chlordiazepoxide capsules because they may have been mislabeled as other medications. The affected drugs were distributed in four western states.
Aidapak Services, LLC is recalling 40 mg atorvastatin calcium tablets that may have been mislabeled as 10 mg atorvastatin or 5 mg finasteride.
Aidapak Services is recalling Hyoscyamine Sulfate ODT tablets that may have been mislabeled as Fluoxetine HCl capsules.
Aidapak Services, LLC is recalling Venlafaxine HCL 100 mg tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling Calcium Carbonate/Cholecalciferol tablets because they may be mislabeled as Repaglinide. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Aidapak Services is recalling 909 tablets of Hyoscyamine Sulfate SL 0.125 mg because they may have been mislabeled as other prescription drugs.
Aidapak Services is recalling Levothyroxine Sodium 88 mcg tablets because they may have been mislabeled as Guanfacine HCl 1 mg tablets.
Aidapak Services, LLC is recalling Nabumetone 500 mg tablets that may have been mislabeled as guaiFENesin ER 600 mg. The FDA classifies this as a Class II recall.
Aidapak Services, LLC is recalling Atorvastatin Calcium 10 mg tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling 10 mg Nortriptyline HCL capsules because they may have been mislabeled as 80 mg Valsartan tablets.